Systemic epigenetic response to recombinant lentiviral vectors independent of proviral integration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8935
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Systemic epigenetic response to recombinant lentiviral vectors independent of proviral integration ; volume:9 ; number:1 ; day:11 ; month:7 ; year:2016 ; pages:1-10 ; date:12.2016
Epigenetics & chromatin ; 9, Heft 1 (11.7.2016), 1-10, 12.2016
- Urheber
-
Arányi, Tamás
- Beteiligte Personen und Organisationen
-
Stockholm, Daniel
Yao, Roseline
Poinsignon, Catherine
Wiart, Thibaut
Corre, Guillaume
Touleimat, Nizar
Tost, Jörg
Galy, Anne
Paldi, Andràs
SpringerLink (Online service)
- DOI
-
10.1186/s13072-016-0077-1
- URN
-
urn:nbn:de:1111-2016071517871
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arányi, Tamás
- Stockholm, Daniel
- Yao, Roseline
- Poinsignon, Catherine
- Wiart, Thibaut
- Corre, Guillaume
- Touleimat, Nizar
- Tost, Jörg
- Galy, Anne
- Paldi, Andràs
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Targeted cell entry of lentiviral vectors
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Reconstructing the immune system with lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Epigenetic modifications of HIV proviral LTRs: potential targets for cure
Production of lentiviral vectors using novel, enzymatically produced, linear DNA
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
High yield sterile filtration process for highly concentrated lentiviral vectors
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Targeted cell entry of lentiviral vectors
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Reconstructing the immune system with lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Epigenetic modifications of HIV proviral LTRs: potential targets for cure
Production of lentiviral vectors using novel, enzymatically produced, linear DNA
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways
High yield sterile filtration process for highly concentrated lentiviral vectors
Lentiviral vectors : with 8 tables
Clinical use of lentiviral vectors
Targeted cell entry of lentiviral vectors
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Epigenetic regulation of lentiviral and retroviral vectors in murine embryonic stem (ES) cells and genetic modification of ES cells with lentiviral vectors for application in regenerative medicine
Reconstructing the immune system with lentiviral vectors
Producing lentiviral vectors for ex vivo organ gene therapy
Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins
Epigenetic modifications of HIV proviral LTRs: potential targets for cure
Production of lentiviral vectors using novel, enzymatically produced, linear DNA
Engineering lentiviral vectors for modulation of dendritic cell apoptotic pathways